Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Keymed Biosciences (2162 HK)
Watchlist
65
Analysis
Health Care
•
Hong Kong
Keymed Biosciences Inc. operates a biotechnology company. The Company focus on the in-house discovery and development of innovative biological therapies. Keymed Biosciences provides services in China.
more
Watchlist
Filings
Presentations
Events
Refresh
Exchange Announcement •
25 Jun 2024 20:14
Sixth Amended And Restated Memorandum And Articles Of Association
Attachment
Exchange Announcement •
25 Jun 2024 20:06
Poll Results Of The Annual General Meeting Held On June 25, 2024
Attachment
Exchange Announcement •
20 Jun 2024 08:15
Voluntary Announcement Results From An Exploratory Clinical Study Of Cm313 In Adults With Primary Immune Thrombocytopenia Were Recently Published In The New England Journal Of Medicine
Attachment
Exchange Announcement •
07 Jun 2024 08:00
Voluntary Announcement New Drug Application Of Stapokibart Injection For The Treatment Of Chronic Rhinosinusitis With Nasal Polyps Accepted By National Medical Products Administration
Attachment
Exchange Announcement •
03 Jun 2024 08:15
Voluntary Announcement Long-Term Efficacy And Safety Data From A Phase Iii Clinical Trial Of Stapokibart Injection At The European Academy Of Allergy And Clinical Immunology (Eaaci) Congress 2024
Attachment
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.33.2
x